期刊文献+

药物性肝病诊治的困惑和建议 被引量:2

下载PDF
导出
摘要 药物性肝病(drug—induced liver diseases)是指在使用某种或几种药物后,由药物本身或其代谢产物引起的肝脏损害。在已上市应用的化学性或生物性药物中,有1100种以上具有潜在的肝毒性,很多药物的赋形剂、中草药以及保健药亦有导致肝损伤的可能。欲更有效地监测和预防日益增多的药物性肝损伤,需要在认识药物性肝病现行诊治原则的基础上。分析其中存在的主要问题。探讨有效可行的诊治策略。
出处 《胃肠病学》 2007年第4期193-195,共3页 Chinese Journal of Gastroenterology
  • 相关文献

参考文献12

  • 1Larrey D.Epidemiology and individual susceptibility to adverse drug reactions affecting the liver.Semin Liver Dis,2002,22 (2):145-155.
  • 2Benichou C.Criteria of drug-induced liver disorders.Report of an international consensus meeting.J Hepatol,1990,11 (2):272-276.
  • 3Danan G,Benichou C.Causality assessment of adverse reactions to drugs --Ⅰ.A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries.J Clin Epidemiol,1993,46 (11):1323-1330.
  • 4Navarro VJ,Senior JR.Drug-related hepatotoxicity.N Engl J Med,2006,354 (7):731-739.
  • 5Sierra F,Torres D.A concise and structured review of drug-induced toxic hepatic disease.Ann Hepatol,2004,3 (1):18-25.
  • 6Polson J,Lee WM,American Association for the Study of Liver Disease.AASLD position paper:the management of acute liver failure.Hepatology,2005,41 (5):1179-1197.
  • 7FDA Working Group.CDER-phRMA-AASLD Conference 2000:clinical white paper on drug-induced hepatotoxicity,November 2000.(Accessed October 20,2006,at http://www.fda.gov/cder/livertox/clinical.pdf)
  • 8Bjornsson E,Olsson R.Outcome and prognostic markers in severe drug-induced liver disease.Hepatology,2005,42 (2):481-489.
  • 9Andrade RJ,Lucena MI,Fernandez MC,et al.Druginduced liver injury:an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.Gastroenterology,2005,129 (2):512-521.
  • 10Bjornsson E.Drug-induced liver injury:Hy's rule revisited.Clin Pharmacol Ther,2006,79 (6):521-528.

同被引文献19

  • 1许英.中药的药物性肝损害30例临床分析[J].现代中西医结合杂志,2005,14(5):600-601. 被引量:18
  • 2王志峰,张晓阳.老年患者药物性肝病的临床分析[J].新疆医学,2005,35(3):23-26. 被引量:4
  • 3徐张巍,许建明.重症药物性肝病21例临床分析[J].临床荟萃,2005,20(14):794-796. 被引量:4
  • 4陈成伟.重视药物性肝病[J].肝脏,2006,11(5):301-302. 被引量:33
  • 5李蕾,王吉耀.药物性肝病发病机制研究进展[J].复旦学报(医学版),2007,34(2):313-316. 被引量:10
  • 6Vincent JL, de Mendonca A, Cantraine F, et al. Usc of SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: result of multicenter, prospective study [J]. Crit Care Med, 1998, 26 (11): 1793-1800.
  • 7Ceriani R, Mazzoni M, Bortone F, et al. Application of sequential organ failure assessment score to cardiac surgical patients [J]. Chest, 2003, 123 (4): 1229-1239.
  • 8Mereno R, Vincent JL, Mates R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care, results of a prospective multicenter study [J]. Intensive Care Meal. 1999, 25 (7): 686-696.
  • 9Aggarwal AN, Agarwal R, Gupta D. Nonpulmonary organ dysfunction and its impact on outcome in patients with acute respiratory falure [J]. Chest, 2.(1)7, 132(3): 829-835.
  • 10Ricardo RF, Raoul NM, Guillermo VM. Analysis of physiologic alterations in intensive care unit patients and their relationship with mortality [J]. Journal of Critical Care, 2007, 22 (2) : 120-128.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部